Alvie Health was founded by NHS consultant surgeon Krishna Moorthy, working as part of Imperial College Healthcare NHS Trust. Since its inception in 2019, the business has provided digital prehabilitation to 13 NHS trusts across 7 Cancer Alliances.

The deal, which makes Reframe Cancer the biggest cancer support business in the UK, will see Reframe Cancer will invest significantly in Alvie Health over the next 12 months as it aims to increase its partnership with the NHS. It will deliver cancer prehabilitation that is risk stratified, delivered at scale, with equitable reach. It is estimated that only 20% of patients currently have access to prehabilitation as part of their cancer journey.

Krishna Moorthy and his full team will stay onboard and Reframe Cancer will add their own management, sales, and marketing teams.

Mark Stephenson, chief executive at Reframe Cancer, said: ‘We see huge potential where Alvie Health has made an impact so far. The National Cancer Plan has also fully committed to cancer prehabilitation, which has already demonstrated enormous clinical value to the NHS in terms of patient outcomes and cost savings.

‘Our investment and acquisition of Alvie Health means we can make a real difference for more cancer patients across the NHS and deliver digital prehabilitation at scale. We are already engaging with ten NHS trusts to help support with cancer-related employee absence, so this is a natural progression and in time we will also support with screening and navigation as a cancer-focused CQC-registered business.

'Our clear outcomes data and expertise from over 12 years of working with cancer patients is unrivalled in the industry, and we are now able to offer full cancer prehabilitation and rehabilitation through our acquisition of Alvie Health and our enhanced digital solutions.'

Krishna Moorthy, founder of Alvie Health, added: ‘The insights and investment from Reframe Cancer will take Alvie Health to the next level. This comes at an important time with the National Cancer Plan committing to digital-first delivery of prehabilitation to all patients from 2028 onwards. I look forward to rolling out our offering further and delivering digital-first cancer prehabilitation at a national scale.'